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EXECUTIVE SUMMARY
Marine biotechnology is a rapidly growing area that is recognised, by policy makers and 
the enterprise sector, as offering significant potential to develop market opportunities for 
new products and processes by enabling greater utilisation of marine biological resources. 
Current research funding activity, supporting efforts to create a sustainable bioeconomy, is 
likely to lead to a growth in marine biotechnology research and commercial activities. Irish 
and international financial support for this research is aimed at as yet largely unexplored 
and underexploited marine resources for use as food, functional foods and nutraceuticals; 
cosmetics and cosmeceuticals; human and animal health – including pharmaceuticals, 
biocompatible materials and medical devices; materials technology; environmental 
bioremediation; and marine model organisms, including the use of marine derived 
materials in bioprocessing. Research within these areas has resulted in an array of new 
products and processes which offer benefits to society and support economic growth. 
The Marine Institute established a Task Force to advise on the steps required to strengthen 
Ireland’s capability to use marine biotechnology to exploit the value of its extensive 
marine bioresources. The Task Force, comprising academic and industry members, 
considered the various national strategies and plans for science, technology, research 
and economic development, and identified market opportunity areas and Irish marine 
biotechnology research capabilities. In supporting the work of the Task Force, the Marine 
Institute completed a number of information-gathering exercises to fill various knowledge 
gaps identified by the Task Force. Following the preparation of a draft report, the Task 
Force, with the support of the Marine Institute, held a workshop attended by researchers 
and companies. This final report of the Task Force takes account of feedback from this 
workshop in developing its recommendations, which are outlined below. 
Specifically, the Task Force recommends the following actions to achieve the ambitious 
targets set in national policies concerning the utilisation of Ireland’s marine bioresources:
• Take steps to ensure Ireland continues to develop the critical infrastructure and 
research capability  required to maintain a leading position in international marine 
biotechnology research, specifically:
a) Build on the achievements and progress made in the NutraMara and 
Beaufort projects by providing funds to create a national virtual Marine 
Bioresources Research Centre with strong connections to other relevant 
supporting scientific capabilities and research centres (nationally and 
internationally). This centre should have the capabilities for species/resource 
identification; the supply, identification and assessment of bio-actives and 
modes of action; and pilot-scale biorefining to eliminate bottle-necks in the 
discovery pipeline. 
b) Focus marine biotechnology research to support food; cosmetics and 
cosmeceuticals; biomaterials; bioprocessing; and human/animal health and 
nutrition product and process development. 
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c) Create, within the Marine Institute, and as an integral component of the
virtual Marine Bioresources Research Centre, an Irish marine bioresources
bio-bank/repository, initially built around the materials and data collected/
generated during the Beaufort and NutraMara projects. This can be enabled
by further developing the current Marine Institute laboratory facilities
to receive, process, preserve, and curate samples, and by implementing
appropriate data management systems to ensure that data relating to
species, samples, processing and the distribution of materials are developed
and maintained to industry standards. A key function of the repository will
be to make data and materials available to the research community and
industry, and to enable Irish participation in international “biobanking”
initiatives.
• Ensure the continuation of the on-going, short to medium-term, and medium to
long-term research priorities identified by the Task Force, aimed at the delivery of
“low-hanging fruit” opportunities.
• Enhance the level of understanding of the distribution and availability of marine
bioresources. In particular, provide knowledge about the distribution, available
biomass and characteristics of commercially relevant species of Ireland’s seaweed
stock.
• Strengthen the methods used to disseminate knowledge from publicly funded
marine biotechnology and bioresources research; thereby increasing the level of
understanding of the potential of these areas to contribute to economic progress,
to provide industry with insights and access to the results of on-going research
activities, and to stimulate greater industry-research interactions, linkages and
collaboration.
• Fully integrate Ireland’s marine bioresources sector into the wider bioeconomy via
initiatives to expand the use of marine bioresources in food, biochemicals and other
bio-based materials applications.
• Overcome barriers related to the absence of scale and financial strength, that
many SMEs in the marine bioresources sector face in attempting to develop marine
biotechnology-enabled products, through the provision of dedicated interventions,
support and technical assistance.
• Identify mechanisms to attract and facilitate the participation of expertise from
areas identified as supportive of marine biotechnology/bioresources, e.g. ocean
observation and mapping, genetics, bioinformatics, chemical synthesis, and process
engineering.
• Develop and implement measures whereby all beneficiaries of public research funds
that involve the collection of marine biological materials within Irish waters provide
samples of all materials collected over the duration of the research grant to a
national repository, at their own cost.
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Introduction
Marine biotechnology is a process that can extract value from the chemical and biological 
diversity of marine organisms and in doing so, apply it to meet societal needs for improved 
well-being. The early stage sampling of the marine biosphere by Irish, European and other 
discovery-oriented researchers, in deep waters, identified marine organisms, including 
bacteria and viruses, with the potential to yield novel compounds with a wide range of 
applications. Similarly, researchers have identified useful compounds in fish processing 
discards. These marine derived materials have the potential to provide components for 
new healthcare, food, environmental and industrial products. As well as new materials, 
marine biotechnology can provide new tools and processes of relevance to industry.
The inclusion of marine biotechnology as a theme in Sea Change1 resulted in Ireland 
being one of the few countries with a strategy for marine biotechnology. Other European 
countries taking a strategic approach to the exploitation of marine biological resources are 
Norway and Denmark. Outside of Europe, Japan, South Korea, China and India are widely 
recognised as the most important players in marine biotechnology, though Korea is the 
only Asian country with a dedicated strategy for marine biotechnology2. 
The EU recognises the potential of marine biotechnology to create new knowledge, 
improve industrial competitiveness and spur economic growth. The imperative to exploit 
living marine resources is prominent in recent EU Policy. Within Blue Growth3, the strategic 
goal is to support sustainable growth in the marine and maritime sectors. Marine 
biotechnology research (so-called Blue Biotechnology) provides a range of novel medical 
molecules, bio-plastics, enzymes and biocides derived from marine organisms. 
European policy also points to the need for food production systems to be more 
sustainable and recognises the role of marine biotechnology to support food production 
and processing. The EU view of the bio-based economy includes deriving maximum value 
in a sustainable manner from all ecosystems. The marine resource includes extensive 
biodiversity and biological materials (algal, animal and microbial), all of which provide 
inputs to processing and consumption. Horizon 2020, the current EU research programme, 
supports this strategy. Under Horizon 2020 Societal Challenge 2: Food security, sustainable 
agriculture and forestry, marine and maritime and inland water research and the bioeconomy 
research funds will be provided to explore novel marine derived biomolecules and industrial 
biomaterials and to exploit the potential of marine derived enzymes4.
The Sea Change strategy, developed by the Marine Institute, recognised that building 
new research capacity in key areas is fundamental to Ireland’s ability to maximise the 
economic potential of the oceans. Investments by the Marine Institute and other Irish 
funding agencies continue to enable this capacity-building process, designed to generate 
the knowledge required to support the creation of high-value marine origin products. 
Harnessing Our Ocean Wealth5 and other national strategies6 recognise the role of marine 
biotechnology in the delivery of food and health-related products, the creation of novel 
biomaterials and processes, and to making improvements in environmental health.
1  Sea Change – a Research Knowledge and Innovation Strategy for Ireland 2006-2013. Marine Instutute, Galway 2006.
2  OECD (2013), Marine Biotechnology: Enabling Solutions for Ocean Productivity and Sustainability, OECD Publishing, Paris.
3  http://ec.europa.eu/maritimeaffairs/documentation/publications/documents/blue-growth_en.pdf
4  https://ec.europa.eu/programmes/horizon2020/en/h2020-section/societal-challenges
5  Marine Coordination Group (2012) Harnessing Our Ocean Wealth – An Integrated Marine Plan for Ireland
6  FoodWise 2025 (2014)
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The overall objective of Ireland’s engagement with marine biotechnology-related research 
is to enhance the country’s international competitiveness through the efficient and 
sustainable use of marine biological resources. Doing so will support economic growth 
and job creation by using marine biotechnology to create new bio-based products and 
processes, protect the marine environment and maintain biodiversity. 
Ireland’s marine environment is an enormous reservoir of biological and chemical diversity 
and is the source of novel materials with the capacity to support the development of 
new products and process applications, ranging from food and food ingredients, to 
polymers for biomedical applications, and more. Exploiting marine diversity requires a 
range of scientific and technological skills to understand, harness and develop enterprise 
opportunities that derive from marine sources. 
The global market for marine biotechnology was expected to reach $4.1 billion in 2015 
with a potential to reach $4.8 billion by 2020 and $6.4 billion by 20257. Behind this growth 
is recognition of the potential of marine biotechnology to extract value from marine 
organisms and deliver materials that are not available from terrestrial sources. There are 
also reports of growth in the European “blue biotechnology” markets of 6-8% per annum, 
annual revenue of up to €1 billion and the creation of 10,000 new jobs over 5 years8.
Marine biotechnology offers many opportunities for “discovery science” and is attractive 
to a wide range of scientific and technological disciplines. However, exploiting the novelty 
of marine organisms as a source of new materials is a major challenge for researchers, 
industry and policy-makers, matched by the challenge of motivating collaboration 
between biologists, botanists, chemists, microbiologists, pharmacologists and engineers – 
many with no background in marine science – to work in this exciting research area.
Marine biotechnology is an enabling technology, which contributes to industrial 
development and enhanced competitiveness and stimulates innovation. Ireland maximised 
the potential of information and communications technology (ICT) to bring about change 
in how people live, work and support innovation. Similarly marine biotechnology can play 
a major part in stimulating innovation in different industry sectors.
7  Smithers Group (2015) The Future of Marine Biotechnology for Industrial Applications to 2025. Available at: http://www.
smithersrapra.com/products/market-reports/biomaterials/the-future-of-marine-biotechnology-for-industrial.
8  ECORYS (2014) Report for DG Maritime Affairs and Fisheries, Study in Support of Impact Assessment work on Blue 
Biotechnology, ECORYS Consultants. Brussels
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Marine Biotechnology Task Force Terms of Reference
The Marine Institute established the Marine Biotechnology Task Force to support the 
continued development of Ireland’s capabilities in marine biotechnology research, 
expand and intensify industry interaction with the research community and advise the 
Marine Institute in the definition and implementation of activities which will support 
national and international policies and strategic initiatives to derive economic returns 
from the exploitation of marine bioresources, as reflected in the EU concept of a diverse 
and dynamic bio-economy. The Task Force terms of reference were to:
• Create a vision for marine biotechnology RTDI in Ireland and define a path by 
which to achieve this vision, such that Ireland’s marine biotechnology-related policy, 
research and infrastructure requirements are fully aligned with industrial/economic 
and commercial opportunities.
• Provide advice on how to develop an Irish marine biotechnology cluster that 
integrates researchers and industry, and positions Ireland as internationally 
competitive in securing research funds.
• Advise the Marine Institute on the most appropriate steps to take to strengthen 
marine biotechnology-related activities in Ireland.
• Provide advice on how best to promote and enhance the awareness of the 
potential of marine biotechnology across a range of industry sectors.
• Define an industry-oriented event to capture and profile the views and expectations 
of firms regarding marine biotechnology opportunities.
• Identify mechanisms to strengthen linkages between researchers in life-sciences 
and researchers working in marine biotechnology-related areas to ensure continued 
access to new knowledge and essential infrastructure to enhance Ireland’s marine 
biotechnology research capabilities.
• Define a strategic plan, advising on its implementation and assessing its impact.
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A Vision for Irish Marine Biotechnology 
By 2020, Ireland will have established an international reputation for the creation of new 
products and processes based on materials isolated from marine biological resources. This 
will be characterised by research activity that:
• Is relevant to existing and emerging industry sectors, such as to enhance 
industrial competitiveness, stimulate economic development and sustain marine 
environments;
• Continues to enable the use of marine origin materials in traditional food- and 
health-related areas and applications;
• Builds upon existing research collaborations to support the emergence of new 
foods, food and health, therapeutics, diagnostics, biomaterials and cosmeceutical 
products and related processes;
• Encourages and supports the engagement of life-sciences research expertise with 
marine sciences expertise, including access to essential research infrastructures; 
• Attracts international funds and positions Irish researchers as leading contributors 
in advancing marine biotechnology research;
• Commercialises research outputs via licence agreements, through new commercial 
ventures and spin-outs and, in particular, through linkages with indigenous firms; 
and 
• Positions Ireland firmly within the European Bioeconomy.
2
10
What is Marine Biotechnology?
Biotechnology is the process by which biological systems are controlled, manipulated 
or modified to produce value-added products. The impact of biotechnology is clear in 
traditional industries such as food and beverages, where it brought about a change in how 
products are produced and influenced the kind of products that could be produced.
Marine biotechnology is concerned with the discovery and exploitation of biological 
materials and processes found in marine environments. Developing insights into the 
genetic and biochemical composition of marine biological resources, deepening our 
understanding of the environmental and other factors which brought them about, and 
understanding their position and role within the marine ecosystem are fundamental in 
realising the economic and societal potential of marine bioresources. 
Marine biotechnology, sometimes referred to as “blue biotechnology”, exploits the diversity 
found in marine environments in terms of the form, structure, physiology and chemistry of 
marine organisms, including microorganisms, many of which have no terrestrial equivalents, 
in ways that enable new materials to be created. Marine biotechnology is a knowledge 
generation and conversion process. It unlocks access to biological compounds and 
provides novel uses for them. By exploring and harnessing marine materials, entirely new 
uses are likely to be found. Already, there are successful marine origin pharmaceuticals, 
novel industrial enzymes, food ingredients, biosensors, drug delivery systems and new 
chemical compounds. 
The process to find marine biological materials to support the development of novel 
products and processes is termed Marine Biodiscovery. This search for marine organisms 
and novel materials has stimulated new methods of exploring marine environments and 
exploiting marine resources. Ireland’s well developed biodiscovery process targets coastal 
and deep-water regions in the search for novel materials and organisms. Results from this 
work have contributed an array of marine biological samples including macro- and micro-
algae, fish and shellfish, marine invertebrates and microorganisms. 
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Marine Biotechnology – An Alignment of Policy Enterprise Objectives
Marine biotechnology is a rapidly developing area, recognised by policy makers and the 
enterprise sector as offering significant potential to fill market gaps for new products, as 
indicated in Blue Growth9. EU member states and countries in the Asia-Pacific rim and 
the Americas10 have led the challenge of developing marine biotechnology. The European 
Commission announced a new European Bioeconomy Strategy in 2012. At its core was the 
twin theme of stimulating research and innovation11. The implementation of this strategy, 
supported by funds from Horizon 2020, stresses the importance of a cross-sectoral and 
interdisciplinary approach in developing Europe’s bioeconomy. The visibility of marine 
biotechnology projects in the Horizon 2020 work programme highlights its potential and 
key role in developing the EU bioeconomy. There is a particular emphasis on the role of 
marine biotechnology research in food security and health, both human and animal, and 
in bioprocessing. Unlocking the potential of the marine environment, utilising knowledge 
generated from within cross-cutting marine research, is at the heart of Horizon 2020. This 
new knowledge contributes to the European Commission Blue Growth initiative, which 
aims to capture and realise the opportunities to create new high-value food and health 
products and, in doing so, to deliver long-term growth and jobs in the blue economy.
The availability of research funds to support the development of a sustainable 
bioeconomy in Europe12 is leading to a growth in marine biotechnology research and 
related commercial activity. Irish and international financial support for research is 
aimed at as yet unexplored and underexploited marine resources for use in food and 
as food ingredients13,14,15 (including functional foods and nutraceuticals); cosmetics and 
cosmeceuticals; marine bio-medicine (including pharmaceuticals discovery and delivery); 
medical devices; materials technology; environmental bioremediation (using marine-
derived materials in bioprocessing); and as marine model organisms. Ireland’s Integrated 
Marine Action Plan – Harnessing Our Ocean Wealth (HOOW)16 defines the Government’s 
vision, high-level goals and integrated actions across policy, governance and business 
to enable Ireland’s marine potential to be realised. Marine biotechnology research, and 
maximising the benefits from marine bioresources, fall within the targets and related 
strategic priorities of HOOW that guide investment in future marine research and 
innovation activities. 
9  European Commission (2012) Blue Growth - opportunities for marine and maritime sustainable growth. 13.9.2012 COM(2012) 
494 final. Brussels
10  OECD (2013) Marine Biotechnology: Enabling Solutions for Ocean Productivity and Sustainability, OECD Publishing: Paris.
11  European Commission (2012) Innovating for Sustainable Growth: A Bioeconomy for Europe. 13.2.2012 COM (2012) 60 final. 
Brussels
12  Biobased Industries Public-Private Partnership (2015) Available at: http://www.bbi-europe.eu/participate/calls-        
proposals-2015
13  Department of Agriculture Food and the Marine FIRM Programme (2015) Available at: http://www.agriculture.gov.ie/
research/2015competitivecallforresearchproposals/
14  Horizon 2020 SC2 Work Programme 2014-2015. Available at: http://ec.europa.eu/research/participants/data/ref/h2020/
wp/2014_2015/main/h2020-wp1415-food_en.pdf
15  Horizon 2020 SC2 Work Programme 2016-2017. Available at: http://ec.europa.eu/research/participants/data/ref/h2020/
wp/2016_2017/main/h2020-wp1617-food_en.pdf
16  http://www.ouroceanwealth.ie/sites/default/files/sites/default/files/HarnessingOurOceanWealthReport.pdf 
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The Marine Resource
Marine biotechnology-enabled products result from exploiting the biological diversity of 
marine environments. A large portion of the surface of the earth (ca. 70%) is covered by 
the oceans and seas, and more than 80% of all organisms live in aquatic ecosystems17. 
Marine species have evolved to live in various environmental niches; as a result they are a 
source of novel chemical and bio-chemical diversity. 
Ireland’s 200,000 hectares of marine territory contains biological and environmental 
diversity, suggesting the existence of an immense chemical diversity within Irish marine 
flora and fauna. There are about 450 species of seaweed in Irish waters, a considerable 
portion of the 600 or so species reliably reported for Britain and Ireland18. Ireland’s marine 
fauna includes more than 3,000 species19 and there are countless bacteria to be found in 
marine sediment and seawater or living within or on other marine organisms20. 
The Marine Biotechnology Tool Kit
The discovery and retrieval of marine organisms from what can be hostile ocean 
environments requires specialised research vessels and collection systems. Ireland 
maintains dedicated research vessels and remotely operated vehicles that can perform 
surveys and collect species/samples in coastal and ocean territories.
Many analytical techniques are employed to isolate, assess and characterise natural 
compounds obtained from marine bioresources. Accelerating this discovery process 
requires support from, and access to, underpinning scientific areas such as marine biology, 
botany, microbiology, biochemistry, molecular biology, genetics and natural products 
chemistry. 
Research in these areas not only contributes to improving our understanding of marine 
origin materials but also creates new and improved tools and defines the protocols 
required to build biological and genetic libraries. Ireland’s expertise in genetics, 
bioinformatics, an array of “omics” technologies and in the development of assays to 
assess bioactivity, all contribute to the search for novel compounds and biomaterials from 
marine organisms. 
Moving from laboratory to commercial scale activity requires facilities to develop 
and demonstrate efficient and sustainable processing systems at each stage of the 
supply chain. Whilst some companies maintain pilot facilities, the majority of firms face 
challenges in proving process capabilities in advance of full-scale production. The required 
infrastructure includes systems to harvest or culture species, to process marine biomass 
into usable fractions, and ensure production targets are technically and economically 
feasible. Whilst Ireland has an excellent dairy products pilot facility, no corresponding 
facility for marine bioresources-based products yet exists.
17  Census of Marine Life Secretariat (2015) Census of Marine Life. Available at: http://www.comlsecretariat.org/research‐ 
activities/coml-and-observing-systems/
18  Natural History Museum (2015) About Algae. Available at: http://www.nhm.ac.uk/research-curation/scientific-resources/
biodiversity/uk-biodiversity/algaevision/about-algae/index.html 
19  Picton BE, Morrow, C. Encyclopedia of Marine Life of Britain and Ireland, National Museums of Northern Ireland. Available 
at http://www.habitas.org.uk
20  Jensen PR, Fenical W. (1996) Marine bacterial diversity as a resource for novel microbial products. Journal of Industrial 
Microbiology, November 1996, Volume 17, Issue 5, pp 346-351
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Ireland’s Emerging Marine Biotechnology Driven Industry
Irish firms already use marine biotechnology to create value from marine bioresources. 
These firms are an emerging sector of Ireland’s wider marine economy and their growth 
reflects the increased use of marine-derived materials in commercial applications. The 
current commercial activity within this sector includes fish, shellfish and seaweed culture 
and harvesting, and the utilisation of these materials as food and food ingredients for 
human and animal consumption. Some firms process seaweeds for use as industrial 
materials, plant fertilisers, animal feed and as bioactives for use in health and cosmetic 
products. Data for this sector show that turnover increased by 5.7% to almost €45 
million between 2007 and 2012, with exports accounting for €14.5 million. In 2010, total 
employment in the sector was approximately 350 persons21. 
Global Markets for Marine Biotechnology
The continued market growth in established and emerging global markets for food-health 
applications, including functional foods, nutraceuticals, food supplements and other 
human and animal health related products, stimulates marine biotechnology-related 
research. This increased level of research in marine bioresources occurs at a time of 
major advances in marine biotechnology, including the provision of dedicated national 
and EU research funds, and the generation of a more industry-led research agenda. The 
ongoing interest from medical, pharmaceutical, aquaculture, nutraceutical and industrial 
sectors, and the search for novel sources of materials, contributes to the growth in marine 
biotechnology research activity. Further, there is evidence of new applications in several 
end-use areas including bioprocessing, environmental remediation and monitoring, 
cosmetics/cosmeceuticals and agriculture/horticulture. 
The global market for marine bioactive substances was expected to have a growth rate of 
more than 4% during the period 2009 to 201522. The largest and fastest growth end-use 
segment for marine biotechnology is healthcare/biotechnology. Further insights into the 
wider markets for products based on marine bioresources include:
• Pharmaceuticals valued at $1.08 trillion in 2011 are forecast to be worth nearly $1.6 
trillion by 202023. 
• The market for marine derived drugs was $4.8 billion in 2011 and was expected to 
reach $8.6 billion by 201624.
• Industrial enzymes valued at $4.2 billion in 2014 are projected to grow at a 
cumulative annual growth rate (CAGR) of 7% from 2015 to 202025.
21  Vega A, Hynes S, O’Toole E. (2015) Ireland’s Ocean Economy – Reference Year: 2012, Socio-economic Marine Research Unit. 
National University of Ireland, Galway 
22  Global Industry Analysts (2011) Markets for marine bioactive substances. Quoted in Aquapreneur: http://aquapreneur.com/
issue-13/global-marine-biotechnology-market-to-reach-us4-1-billion-by-2015/
23  PWC (2012) From vision to decision – Parma 2020 Available at: http://www.pwc.com/gx/en/pharma-life-sciences/pharma2020/
assets/pwc-pharma-success-strategies.pdf
24  BCC Research (2011) Global Markets for Marine-Derived Phramaceuticals. Available at: http://www.bccresearch.com/
market-research/pharmaceuticals/marine-derived-pharma-markets-phm101a.html
25  Markets and Markets (2015) Industrial enzymes market report 2015. Available at: http://www.marketsandmarkets.com/
PressReleases/industrial-enzymes.asp
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• The global functional food market is forecast to reach $54 billion (€43 billion) by 
2019, an increase of 25% from 201326.
• The global cosmeceuticals market is growing at a CAGR of 9% and is expected to 
reach $60 billion by 202027.
• The global market for biomaterials is expected to reach $130 billion by 2020 and 
grow at a CAGR of 16%28.
• The global market for advanced drug delivery systems was valued at $151.3 billion 
in 2013 and forecast to reach nearly $174 billion in 201829.
• The global bone grafts and substitutes market was valued at $2.35 billion in 2014 
and is anticipated to expand at a CAGR of 4.5% from 2015 to 2023 to reach $3.48 
billion in 202330.
• The next generation biologics market, worth $1.5 billion in 2013, is set to continue 
to grow and reach $30 billion by 202431. 
The Norwegian Response to Global Opportunities
Norway, like Ireland, prioritised marine biotechnology research and set targets, in the 
context of a broader national bioeconomy strategy, to use marine biotechnology to exploit 
underutilised marine bioresources. It identified marine biotechnology as a thematic priority 
in harnessing the potential of the oceans to stimulate innovation in food and health-
related areas. This move was supported by related national strategies in marine genomics, 
marine bioprospecting, aquaculture and marine foods production. In acknowledging 
the relevance of marine biotechnology to emerging areas of economic growth, Norway 
created a marine biotechnology research agenda and established a national marine 
biomaterials biobank. The interaction between these strategies, coupled with the creation 
of strong links to industry by research institutions and industry centres, in the context of 
a long-term vision, aims to ensure that marine biotechnology will drive innovation. The 
Norwegian strategy recognises the importance of institutions working together on a 
national basis to harness key research strengths, utilise core infrastructure and build strong 
research communities, making them attractive partners for international consortia. 
26  Leatherhead Food Research (2014) Future Directions for the Global Functional Foods Market. Quoted in Nutraingredients. 
Available at: http://www.nutraingredients.com/Markets-and-Trends/Functional-foods-market-is-expected-to-grow-25-by-
2017-Leatherhead
27  Global Information (2015) Market Research Report – 263147 Global Cosmeceuticals Market Outlook 2020 Available at: 
http://www.giiresearch.com/report/rnc263147-global-cosmeceuticals-market-outlook.html
28  marketsandmarkets.com (2015) Biomaterials Market by Type of Material - Global Forecast to 2020 Available at: http://www.
marketsandmarkets.com/Market-Reports/biomaterials-393.html
29  BCC Research (2014) Advanced Drug Delivery Systems. Quoted in Drug Development and Delivery November/December 
2014. Available at: http://www.drug-dev.com/Main/Back-Issues/GLOBAL-DELIVERY-MARKET-Advanced-Drug-Delivery-
Syst-804.aspx
30  Transparency Market Research (2015) Bone Grafts and Substitutes Market - Global Industry Analysis, Size, Share, Growth, 
Trends and Forecast, 2015 – 2023. Available at: http://www.transparencymarketresearch.com/bone-grafts-substitutes-
market.html
31  Visiongain (2014) Market Report Next-Generation Biologics: R&D, Industry and Market Quoted in Pharmaceutical 
Manufacturing June 2014 Available at: http://www.pharmamanufacturing.com/articles/2014/next-gen-biologics-market-
worth-30b-by-2024/
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Key Growth Areas in Ireland Relevant to Marine Biotechnology
The output from Ireland’s marine biotechnology research is relevant to the major growth 
opportunities in Ireland in health and well-being, human and animal therapeutics, food, 
biomaterials, and bioprocessing. Ireland’s marine biotechnology capacity is increasing 
and Irish firms are capturing a share of the global market opportunity. Key elements of 
Ireland’s industrial economy that are closely associated with evolving markets for marine 
biotechnology-based materials include:
• Food – The food sector, largely an indigenous sector worth €2.6 billion per annum, 
provides 163,000 jobs linked to food32. It is increasingly research-intensive and 
driven by biotechnology, possesses an international reputation for dairy origin 
functional foods and a rapidly developing reputation for marine functional foods 
research.
• Pharmaceuticals – Nine of the world top ten firms have a base in Ireland. In 
addition, there are some 50 indigenous firms in the sector. Exports from the sector 
top €50 billion per annum (2013) and the sector employs 25,00033. 
• Medical devices – Eight of the world top ten firms have a strong presence in 
Ireland, as well as some 100 indigenous firms. The sector employs 24,000 in 160 
firms and generates an annual revenue of €6 billion34.
• Aquaculture – Comprising a world leading aquaculture MNC and indigenous 
SMEs, there are 850 licensed operations engaged in producing finfish and shellfish 
for export markets. The sector employs close to 2,000 and output in 2014 was 
valued at €115 million35.
Ireland’s seaweed sector was a first mover in exploiting marine biotechnology to support 
its growth into high-value-added products. Already eight firms, from an estimated 20, are 
positioned in the functional foods, nutraceuticals, cosmetics and agriculture/horticulture 
sectors36. Annual sales from this new marine-bio-based sector grew rapidly over a three 
year period to reach an estimated €18 million in 201437. Interest in Ireland’s seaweed 
resource and its utilisation is expanding in line with international trends.
32  Department of Food, Agriculture and the Marine (2015) FoodWise2025 – A 10 year vision for the Irish Agri-food industry. 
Dublin: DAFM 
33  IBEC (2014) Pharma Chemical Ireland sector profile Available at: http://www.pharmachemicalireland.ie/Sectors/PCI/PCI.nsf/
vPages/About_us~industry-profile?OpenDocument
34  Enterprise Ireland (2014) Medical Devices Sector profile. Available at: https://www.enterprise-ireland.com/en/Source-a-
Product-or-Service-from-Ireland/Sector-and-Company-Directories/Medical-Devices-Sector-Profile.pdf
35  Bord Iascaigh Mhara (2014) BIM Annual Aquaculture Survey. Available at: http://www.bim.ie/media/bim/content/downloads/
BIM%20Aquaculture%20Survey%202014.pdf
36  Cybercolloids, ArraMara, Oilean Glas, Marigot, BioAtlantis, Brandon Products, Voya and Irish Seaweed Processors
37  Bord Iascaigh Mhara (2014) Developing seaweed farming to produce a high-value product. Available at: http://www.bim.ie/
our-work/projects/developingirishseaweedfarmingforhighvalueproducts/ 
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Target Opportunity Areas
The emergence of a European bioeconomy, focused on the conversion of renewable 
resources from terrestrial and marine environments into food, feed and related bio-
based products, contributes to meeting Europe’s grand challenges for the 21st century38. 
Effecting a transition to the bioeconomy is supported by funds for research to discover 
new applications for the sustainable use of biomaterials. However, there are already active 
and growing global markets for products, based on or incorporating marine biological 
materials, as described below. 
Therapeutics
Despite a lack of familiarity with the marine environment and a dependency on terrestrial 
sources for drug biodiscovery, there is an increased awareness of the potential of marine 
compounds as pharmaceuticals resulting from several notable market successes. Marine 
biotechnology research led to compounds, extracted from marine organisms, being used 
in several anti-cancer treatments (Cytostar-U/ViraA sales of $68 million in 2011; Yondelis 
sales of €76 million in 2014)39,40. There are reports of increased commercial attention on 
the novelty, diversity and drug-like characteristics of the compounds produced by marine 
organisms. In excess of 20,000 marine-origin natural products have been discovered in 
the past 20 years, from which some 40 marine natural product based drugs are in various 
stages of clinical development41. 
Marine origin compounds demonstrate a broad range of bioactive characteristics, 
including anti-tumour, anti-microtubule, anti-proliferative, photo-protective, antibiotic 
and anti-infective, in various assays42. Results like these make marine natural products an 
interesting and potentially beneficial source of high-value pharmaceutical ingredients. 
The diversity of Ireland’s untapped marine resource – sponges, bacteria, algae and other 
species – is a source of novel bioactives with potential for utilisation as pharmaceutical 
compounds. 
38  European Commission (2012) Innovating for Sustainable Growth: A Bioeconomy for Europe, DG Research and Innovation 
Brussels July 2012
39  Zeltia (2015) Highlights Report at 31st December 2014. Available at: https://www.pharmamar.com/wp-content/
uploads/2015/10/INFORME-DICIEMBRE-2014-en1.pdf
40  ABS Initiatve (2014) Sales data according to EvaluatePharma® (UK), a service of Evaluate Ltd. (UK) www.evaluategroup.com. 
Quoted in Relevance of Marine Bioprospecting for ABS Frameworks, The ABS capacity development initiative. Available 
at: http://www.abs-initiative.info/fileadmin/media/Knowledge_Center/Pulications/Fact_sheet/Relevance_of_Marine_
Bioprospection_in_ABS_context_July_2014.pdf
41  Mayer ASM. (2015) Marine Pharmaceuticals: The Preclinical Pipeline, Midwestern University. Available at: http://
marinepharmacology.midwestern.edu/preclinPipeline.htm 
42  Martins A, Vieira H, Gaspar H, and Santos S, (2014) Marketed Marine Natural Products in the Pharmaceutical and 
Cosmeceutical Industries: Tips for Success. Mar Drugs. 2014 Feb; 12(2): 1066–1101
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Medical devices
Eighteen of the world top 25 medical devices and diagnostics companies have a 
manufacturing presence in Ireland. Ireland is now the second largest exporter of medical 
products in Europe, behind Germany. There are 400 companies in Ireland (of which half 
are Irish-owned) involved in developing, manufacturing and marketing a diverse range of 
products and services. This includes disposable plastic and wound care products, precision 
metal implants (including pacemakers), micro-electronic devices, orthopaedic implants, 
diagnostics, contact lenses and stents43. Ireland’s medical device sector is undergoing a 
transformation, from being predominantly manufacturing based to become more research 
intensive. This change of focus will result in a collaboration involving a range of partners, 
including research institutions, clinicians, manufacturing companies and government 
agencies.
Compared to more traditional sources, marine biomaterials offer the medical 
device sector access to materials with unique properties including biodegradability, 
biocompatibility, topography and mechanical strength. Though the commercial use of 
marine biomaterials remains in its infancy, they offer significant opportunities for use in a 
range of medical applications. Whilst there is a strong emphasis on the development of 
biomaterials for human tissue engineering, dental and bone fillers, and in wound healing, 
current research highlights their use as skin substitutes, adhesives, cartilage replacement 
and in drug delivery44. The sources of these marine biomaterials include macro- and 
micro-algae, coral, sponges, crustaceans and finfish. 
Food products and ingredients
Ireland’s food industry is largely an indigenous sector worth €2.6 billion per annum. 
The sector is increasingly research-intensive and driven by biotechnology. It possesses 
an international reputation for dairy origin functional foods and a rapidly developing 
reputation for marine functional foods research45. There is a global demand for novel 
ingredients to support the growth in functional foods. In this fast growing global market, 
the sales of probiotic and other functional food ingredients are expected to continue to 
rise. As a result of the market success and beneficial health effects of integrating fish oils 
into foods, new sources of functional ingredients are being sought. Early results from Irish 
research to discover novel bioactives from marine biological resources are promising and 
can enhance the performance of Ireland’s food sector in building on the successes of 
developing niche food ingredient products.
Ireland’s marine foods sector is well positioned to create added-value products by 
more intensive processing of marine bioresources. Opportunities exist to produce food 
ingredients, nutraceuticals, functional foods, food supplements and cosmeceuticals, and 
for firms to diversify into new market areas. These opportunities can be realised by the 
sustainable exploitation of marine biological resources, and by capturing value from 
within the more traditional processing of marine species for food and non-food use. The 
potential of the marine as a source of novel compounds for food and other health-related 
applications continues to attract the interest of key players in policy, research and industry 
and is highlighted in national strategies. 
43  Irish Medical Devices Associoation - About the MEDTECH sector. Available at http://www.imda.ie/Sectors/IMDA/IMDA.nsf/
vPages/Medtech_sector~about-the-medtech-sector!OpenDocument
44  Kim Se-Kwon. (2013) Marine Biomaterials Characterisation, Isolation and Applications. CRC Press, Boca Raton.
45  Department of Food, Agriculture and the Marine (2015) FoodWise2025 – A 10 year vision for the Irish Agri-food industry. 
Dublin: DAFM 
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Cosmeceuticals
The global market for cosmetics products was $460 billion in 2014 and is set to reach 
$675 billion by 2020. Within this market cosmeceuticals is the fastest growing segment46. 
These high-value products, which are a relatively recent addition to the cosmetics and 
personal care markets, provide therapeutic-like benefits to users. The discovery of new 
ingredients has contributed to the development and growth of cosmeceutical products. 
There is a strong market demand for organic and natural ingredients in cosmetic and 
cosmeceutical products. Traditionally, extracts from plants have formed the basis of 
cosmeceutical products. However, firms from the marine sector are emerging as suppliers 
to cosmeceutical manufacturers, with some specialist ingredient suppliers providing 
compounds derived from salmon eggs, micro- and macro-algae, fish skins, and plants 
found in coastal regions. Responding to the demand from the cosmeceuticals sector 
for extracts from seaweeds, OceanBasis, a German company, established a seaweed 
aquaculture activity in the Baltic Sea47. 
Industrial products/processes
The development and use of marine-derived biomaterials remain in its infancy. Scientific 
capabilities and research infrastructures have developed to the point of being able to 
be used to explore the marine environment for sources of novel materials. High on the 
agenda of the industrial biotechnology sector is the search for new materials. Increasingly, 
firms require customised, individual enzymatic solutions to produce their products. Marine 
microbes have already demonstrated their potential as a source of novel enzymes used in 
food, detergent, pharmaceuticals and fine chemicals48. An expanding area of interest, to 
various industry sectors and the bioeconomy, is biopolymers, some of which have already 
been isolated from marine macro-algae and microorganisms. Many applications exist for 
these materials including biodegradable plastics, food additives, and medical polymers. 
Environmental remediation
Europe’s plan to expand the bioeconomy is underpinned by activities in the agriculture, 
forestry, fisheries and aquaculture, and other bio-based industries. Addressing the 
challenges of food security, protecting human health, and safeguarding the natural 
environment are priorities for Europe’s bioeconomy. Marine biotechnology can have a 
substantial impact in protecting and sustaining the marine environment. The scope for 
marine biotechnology to contribute to the protection and management of the marine 
environment is likely to expand in line with the increased utilisation of the oceans. There is 
a role for marine-derived biosensors, biosurfactants, enzymes, and even marine organisms, 
in monitoring marine environments and facilitating remediation in the aftermath of 
pollution or other contamination events and in reducing biofouling. The marine is home to 
a number of bacteria that rely on petroleum oil  hydrocarbons as a prime source of their 
energy. These bacteria become abundant in oil-contaminated waters and therefore offer 
potential as the basis for products that could be used in the remediation of the marine 
environment following oil spills49. 
46  Research and Markets (2015) Global Cosmetics Markets. Available at: http://www.researchandmarkets.com/research/f2lvdg/
global_cosmetics 
47  Organic Monitor (2012) Marine Ingredients in Cosmetics: Sustainability implications. Available at: http://www.organicmonitor.
com/r1710.htm
48  Zhang C, Se-Kwon Kim (2010) Research and Application of Marine Microbial Enzymes: Status and Prospects. Mar Drugs. 
2010; 8(6): 1920–1934.
49  Zhang C, Se-Kwon Kim (2010) Research and Application of Marine Microbial Enzymes: Status and Prospects. Mar Drugs. 
2010; 8(6): 1920–1934.
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Agriculture and horticulture
Ireland has a long history in the use of seaweed as an agricultural fertiliser, with large kelp 
species, available as cast or washed up seaweed, once commonly used for this purpose. 
Today, raw and milled seaweeds harvested from the wild stock, particularly Ascophyllum 
Nodosum, continue to be used as fertilisers and soil conditioners50. The use of products 
based on seaweed extracts is common practice in the horticulture sector to increase 
yield, nutrient uptake and pest resistance in fruit, vegetable and flower crops51,52. The use 
of seaweed as a feed additive is well established in the agriculture sector, stemming from 
the time when animals reared in coastal regions were allowed to graze on washed-up 
seaweeds. Coinciding with evidence concerning the beneficial role of seaweed in diets for 
cattle53, sheep54, pigs55 and horses56, interest in the use of seaweed in animal nutrition and 
health is rising. Driven by changes in the regulation of veterinary drugs, new systems of 
animal production are also required. Research results point to the potential of including 
seaweed extracts in animal feeds to counter nutritional deficiency, bacterial infection, and 
low weight-gain, negating the need for growth promoting antibiotics57. The aquaculture 
sector is calling for the development of novel, sustainable feed sources and ingredients for 
finfish and shellfish production. The inclusion of seaweed or micro-algae extracts in such 
diets is seen as a possible means of reducing the dependency on the use of fish meal and 
fish oils in feed, thereby reducing pressures on wild stocks58. 
50  OGT Product Data (2015) Available at: http://ogt.ie/research-ascophyllum/ascophyllum-nodosum/
51  Blunden G (1972) The effects of aqueous seaweed extract as a fertilizer additive. Proc Int Seaweed Symp 7:584–589
52  Sangha JS, Kandasamy S, Khan W, Bahia, NS, Rudra P, Singh RP, Critchley,AT and Prithiviraj B. (2015) λ-Carrageenan 
Suppresses Tomato Chlorotic Dwarf Viroid (TCDVd) Replication and Symptom Expression in Tomatoes. Mar Drugs. May; 
13(5): 2875–2889
53  Rey-Crespo F, López-Alonso M, Miranda M. (2014) The use of seaweed from the Galician coast as a mineral supplement in 
organic dairy cattle. Animal. Apr;8(4):580-6
54  Hopkins DL, Clayton EH, Lamb TA, van de Ven RJ, Refshauge G, Kerr MJ, Bailes K, Lewandowski P, Ponnampalam EN. (2014) 
The impact of supplementing lambs with algae on growth, meat traits and oxidative status. Meat Sci. 2014 Oct;98(2):135-41
55  Lynch MB, Sweeney T, Callan JJ, O’Sullivan JT and O’Doherty JV ; (2010) The effect of dietary Laminaria hyperborea 
derived laminarin and fucoidan on nutrient digestibility, nitrogen utilisation, intestinal microflora and volatile fatty acid 
concentration in pigs’ Journal of the Science of Food and Agriculture, 90 (3):430-437.
56  Moore-Colyer, M (2009) Improving Horses’ Diets with Aquacid. Report by The Royal Agricultural College. Cirencester
57  Leonard SG, Sweeney T, Pierce KM, Bahar B, Lynch BP, O’Doherty JV. (2010) The effects of supplementing the diet of 
the sow with seaweed extracts and fish oil on aspects of gastrointestinal health and performance of the weaned piglet. 
Livestock Science 134: 1-3: 135-138
58  Gulf Seafood Institute (2014) News Item - International Team of Scientists Exploring Use of Algae for Aquaculture 
Feedstock. Available at: http://gulfseafoodnews.com/2014/10/19/scientists-exploring-use-of-algae-for-aquaculture-
feedstock/
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Aquaculture
Population growth, food security, and health and well-being, are the prime drivers of the 
global food industry. Meeting the future demand for food requires global food production 
to increase by 70% by 205059. The United Nations Food and Agriculture Organisation 
(FAO) reports that world consumption of fish averages 19 kg per person/annum and is 
rising60, at the same time as global fish stocks are declining as a result of overfishing61. 
Aquaculture is a major opportunity area for marine foods production and for marine 
biotechnology. Realising the economic, social and regional benefits of aquaculture 
requires access to knowledge. There is a role for marine biotechnology research to 
enhance the development of aquaculture by enabling measures that minimise and 
mitigate environmental impacts, including treatment of waste, supporting new production 
systems (including breeding/hatchery/genetics), nutrition and health, and biosecurity. The 
results from research in these areas are relevant to the industry and also support policy 
development. Ireland’s marine biotechnology community is well placed to support the 
call by the European Aquaculture Technology Platform for the improved management of 
the biological lifecycle, the development of sustainable feed production, and improved 
management of aquatic animal health and welfare62.
Ireland’s Strengths in Marine Biotechnology Research
National and international policy and business forecasts highlight the economic 
contribution of marine biotechnology research to different industry sectors. Significant 
advances in biological research are occurring, particularly in areas associated with 
“omics”, “systems biology” and synthetic biology. These developments stimulate marine 
biotechnology research and bring new expertise to work with marine bioresources. 
Ireland has an established marine biotechnology research community that is supported 
by national and international funds. Active university-, research institute- and institute 
of technology-based projects exist in areas related to biomaterials, bioprocessing, food 
ingredients and functional foods, drugs and other therapeutic products, animal health and 
agriculture, aquaculture, medical devices, cosmetics and environmental remediation. 
Achieving equilibrium between the exploitation of marine bioresources for commercial 
purposes and the need to sustain natural stocks is essential to maintain marine 
biodiversity. This challenge is reflected in the role of marine biotechnology in supporting 
aquaculture, as well as the increased interest in understanding the largely undiscovered 
potential of marine organisms to contribute to the development and growth of other 
industry sectors. Embodied within marine biotechnology research is expertise that can 
contribute to the realisation of Ireland’s economic targets for revenue growth from marine 
resources and manufacturing activities. 
59  FAO (2009) How to feed the world in 2050 – Issues Brief. Available at: http://www.fao.org/fileadmin/templates/wsfs/docs/
expert_paper/How_to_Feed_the_World_in_2050.pdf
60 FAO (2014) The State of World Fisheries and Aquaculture. Rome: Food and Agriculture Organisation of the United Nations
61  FAO (2009) General situation of world fish stocks United Nations Food and Agriculture Organization (FAO) Available at: 
http://www.fao.org/newsroom/common/ecg/1000505/en/stocks.pdf
62  EITP (2012) VISION – The Future of European Aquculture. Available at: http://www.eatip.eu/Default.asp?SHORTCUT=92
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Research capacity and capabilities 
Ireland’s marine biotechnology research base includes an estimated 64 permanent 
academic/research staff working in such areas as microbiology, chemistry, botany, 
biochemistry, genetics and a range of marine related biological sciences. These Principal 
Investigators (PIs) currently direct the work of 76 other researchers, 32 at Ph.D. level and 44 
Post-Doctoral Fellows, on a range of marine biotechnology projects. 
Thematic areas of global opportunity, which correspond to areas of science where Ireland 
has research expertise, include:
• Marine Bioactive Compounds and Bioproducts – a process of discovery, extraction 
and characterisation of materials from marine macro- and micro-organisms, fish, 
marine invertebrates, algae, and waste materials stemming from processing of fish, 
shellfish and algae.
• Algal Biotechnology – marine algae have been found to contain quantities of high-
value compounds with chemical, food, pharmaceutical, nutraceuticals, cosmetic 
and agricultural applications. Examples of compounds derived from marine algae 
are polysaccharides, polyphenols and pigments. Marine algae are known to 
have a range of environmental applications, including pollution monitoring and 
bioremediation, in addition to being a source of materials with antioxidant, anti-
cancer, antibiotic and other properties. 
• Marine microorganisms – that may have developed unique metabolic and 
physiological capabilities with applications in pharmaceuticals, biomaterials and 
industrial processes.
• Aquaculture – the application of molecular biotechnologies, such as “omics” 
technologies to support aquaculture development (including finfish, shellfish and 
algae); as food products; and as sources of novel extracts. 
• Marine Molecular Biology – to characterise, isolate and manipulate the molecular 
components of cells and organisms from the marine environment. The techniques 
can be used to identify the presence of a specific organism in a water sample, 
differentiate between similar looking species and identify genetic structures. 
• Marine Metagenomics – many marine microbial communities cannot be cultured. 
Metagenomic-based approaches allow an assessment of the microbial genomes 
present in marine environments and in doing so enable access to protein-encoding 
genes from uncultivable marine microorganisms.
• Biofouling – investigating the mode of action of bioactive compounds (at genomic, 
transcriptomic and proteomic levels) against larval settlement; mechanisms of 
settlement and attachment of micro-organisms, invertebrates, ascidians and 
macro-algae.
• “Omics” in Marine Biotechnology – the development and use of tools and 
approaches to understand the biochemistry, physiology and phylogeny of marine 
organisms. Typically, this entails an integrated approach involving sequencing, 
bioinformatics, transcriptomics, proteomics and phylogenetic analysis, to enable 
rapid gene discovery and to use these findings in developing novel products from 
marine organisms.
• Glycobiology – characterising marine glycoconjugates for biomedical and 
biotechnological applications.
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• Biomaterials and Nano-biotechnology – the discovery and application of natural 
molecular mechanisms and proteins as found in marine organisms to provide new 
materials. Typical examples include semi-conductors, bone repair, delivery systems 
and medical devices.
Recent achievements 
Marine Institute grants have supported the development of new research capacity and 
encouraged scientists from the life sciences, marine biological sciences and the food/
nutritional sciences to collaborate on marine biotechnology research leading to the 
creation of a national programme in Marine Functional Foods and Marine Biodiscovery. 
Known as NutraMara and the Beaufort Marine Biodiscovery project respectively, this 
capacity- and capability-building research comprises 25 Ph.D. students, 20 Post-Docs and 
21 PIs working across seven institutions. In these projects, which focus on the sustainable 
exploitation of marine bioresources, Irish researchers target marine organisms as a 
source of new materials for use in food and health applications. Both projects involve the 
collection and screening of marine organisms and the generation of research outputs to 
support the creation of new bioproducts and processes. Outputs include in excess of 150 
peer-reviewed publications in addition to presentations, posters, books and book chapters. 
These projects have also established sample repositories and marine biomaterials 
databases, which can be made available under licence to other researchers.
Excluding the funds provided to NutraMara and the Beaufort Marine Biodiscovery Project 
(€12.5m), the PIs involved in these projects secured close to €10 million in additional 
research grants in 3 years from Enterprise Ireland, Science Foundation Ireland, the 
Environmental Protection Agency, the Department of Agriculture, Food and the Marine 
and the EU Framework Programme. 
New research partnerships and collaborations within Ireland and Europe have developed 
from within the NutraMara and Beaufort research projects. As a direct result of their 
participation in the Beaufort Biodiscovery project, Irish marine biotechnology researchers 
are participating in three EU research framework projects. Additionally, collaborations 
between NutraMara and Beaufort PIs resulted in new research grant awards of €4.5 million 
from the Department of Agriculture, Food and the Marine FIRM Programme. 
In addition to the success of public sector researchers in securing European funds for 
marine biotechnology research, four Irish marine bioresources companies involved in 
processing seaweeds – Bioatlantis, Cybercolloids, Marigot and Brandon Products – were 
also successful in securing EU research funds.
Existing research infrastructure
Research infrastructures located at the Marine Institute and in the higher education sector 
support Ireland’s capacity to engage in marine biotechnology research. The availability 
of ocean-going research vessels equipped with an array of mapping and sample retrieval 
systems, including remotely operated vehicles, enable researchers to reach the deepest 
areas of Ireland’s marine territories. The collaborative nature of marine biotechnology 
research in Ireland ensures access to “state of the art” physical, biological and chemical 
analytical facilities in the higher education institutions. In addition to accessing equipment, 
researchers draw upon expertise in genomics, molecular methods, systems biology, 
bioinformatics and other related areas. Major institutional links created within the Beaufort 
and NutraMara projects enable access to facilities and specialists at research institutes 
and centres such as the Conway Institute, the Ryan Institute, the Regenerative Medicine 
Institute, the Environmental Research Institute and the Alimentary Pharmabiotic Centre.
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Conditions Required to Develop Irish Marine Biotechnology Research
Exploring marine environments and converting marine biomass into new products and 
processes relies upon contributions from diverse scientific, technological and engineering 
disciplines. The many opportunities for marine biotechnology research to contribute 
to the food, health and biomaterials sectors, demand inputs from multiple scientific 
and technological sources. Creating the conditions to deliver the promise of Ireland’s 
bioresources sector requires researchers, industry and policy to work closely together. A 
relatively few generic “imperatives” have to be met to create the environment for Irish 
marine biotechnology research and innovation to flourish, as outlined below. These 
include:
• Retaining a focus on innovative scientific and engineering excellence in all aspects 
of and at all stages in the evolution and application of knowledge;
• Continuing to provide funds for research designed to exploit Ireland’s marine 
resources other than as a source of food; 
• Continuing efforts to establish a greater level of visibility and recognition for marine 
biotechnology in national and EU policy;
• Employing greater precision in the application of research effort towards the “low-
hanging fruit” to secure early successes that will contribute to Ireland’s ability to be 
globally competitive in food, health and biomaterials-related business activity;
• Reinforcing the deployment of a sustainable approach to the exploitation of 
marine bioresources; and
• Providing a focal point for marine biotechnology research as a means of 
integrating leading and relevant related capabilities to perform internationally 
competitive research with commercial outcomes.
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Marine Biotechnology Research Priorities
Ireland’s National Research Prioritisation Exercise (NRPE) stressed the importance of 
biotechnology for enterprise-driven research in areas such as Sustainable Food Production 
and Processing (Priority Area I), and Foods for Health (Priority Area H)63. Other priority 
areas – therapeutics, medical devices, processing technologies and novel materials – can 
also benefit from the results of marine biotechnology research. 
A major challenge for marine origin bioproducts is the production of biomass. Providing 
sufficient biomass, maintaining consistency of the biomass supply chain, and ensuring the 
security of supply have to be addressed in ways that address concerns for the environment 
and the concept of sustainable production. Overcoming engineering and environmental 
challenges, which could otherwise be limiting factors in biomass production and the use of 
marine bioresources, is critical. Deciding where and how marine biomass is grown requires 
decision-making processes to take into account the various societal, commercial, scientific 
and environmental constraints. 
The definition of research, and related opportunities to support the growth of Ireland’s 
marine bioresources sector, takes account of current research projects and priorities. This 
approach builds on the research capabilities and capacity developed in recent years and 
ensures that current research priorities can be met. In doing so, existing research activities 
will remain active, as in the case of exploring, assessing and profiling marine bioresources, 
and the requirement that harvesting and culture of marine bioresources are managed 
sustainably. Current research priorities will be met by supporting on-going, short- and 
medium-term research as outlined below. 
On-going research
• Engage in research to assess, profile and maximise the sustainable use of marine 
bioresources for applications in human and animal food, food ingredients, 
therapeutic compounds, and as novel materials and processes.
• Continue the mapping and assessment of Ireland’s marine bioresources.
Short to medium-term research
• Maintain a focus on industry-led research, to enable the maximum use of available 
biomass, from available and known materials (e.g. seaweeds, processing waste 
and aquaculture products), in human and animal foods, functional ingredients, 
cosmeceuticals, agricultural stimulants, and for animal health.
• Direct research activity towards marine organisms as a source of novel enzymes for 
use in the process industry sector (e.g. food, fine chemicals, consumer products and 
biopharmaceuticals). 
63  Forfas (2012) Research Prioritisation Steering Group Report. Available at https://www.djei.ie/en/Publications/Publication-files/
Research-Prioritisation.pdf
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• Develop and deploy techniques to culture marine organisms, as an alternative 
source of biomass, for input to the biodiscovery pipeline, whilst also deploying 
marine biotechnology to enhance breeding techniques, and as a means of 
improving the competitiveness of the supply chain.
• Maximise the potential for marine biotechnology to contribute to improved 
management and decision-making regarding the use of marine biological 
resources, supporting an ecosystems approach to fisheries management, and 
investigating the effects of climate change on primary producers, fishery and 
aquaculture species.
• Investigate the potential for marine biotechnology to make improvements in the 
production efficiencies of marine origin food products.
Medium to long-term research
• Explore marine bioresources as potential sources of therapeutics, diagnostics 
and other materials for use in human health applications (e.g. drugs and medical 
devices). 
• Engage in research that will yield novel enzymes from marine bioresources, 
including research that seeks to deliver new technologies to support the screening, 
purification and production of marine derived enzymes on an industrial scale. 
• Employ novel culturing techniques to create marine biomass with defined chemical 
and biological characteristics as a sustainable source of high value materials for 
use in food and health applications.
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Future Direction of Ireland’s Marine Biotechnology Research
Many national and European policy documents stress the importance of maximising 
the economic potential of marine biological resources and the contribution of marine 
bioresources in developing Europe’s bioeconomy and Ireland’s marine economy. Ireland 
is a recognised leader in European marine biotechnology research, being one of the first 
countries to target marine biotechnology towards the exploitation of marine biological 
resources. 
Ireland’s flagship marine biotechnology research initiatives – NutraMara and Beaufort 
Marine Biodiscovery programme – have close links to industry and are engaged in 
research that is relevant to Ireland’s emerging high-growth industry sectors. Together, 
they continue to attract new research funds, train research talent and collaborate in 
international research projects. The research outputs from NutraMara and Beaufort are 
relevant to policy and economic targets set out in Harnessing Our Ocean Wealth and 
other national strategies and provide a solid foundation on which to build future marine 
biotechnology research activities. The report of Our Ocean Wealth Development Task 
Force64 identified the harvesting and use of Ireland’s marine bioresources as a significant 
component of the marine economy and recommends the creation of a research-driven 
cluster based on existing capabilities in marine functional foods and biodiscovery, to 
enhance the utilisation of marine biomass, develop novel processes and add value to 
marine bioresources. 
It is essential to build upon the leadership, scientific excellence, and research achievements 
of the Principal Investigators involved in NutraMara and Beaufort in developing future 
marine biotechnology research activity. Adopting a focused, incremental approach for 
future marine biotechnology research will ensure enhanced research performance and 
strengthened links between the research and commercial sector. Such an approach 
requires targeting research towards specific marine bioresources, implementing a 
prioritised research agenda and the creation of new partnerships. The returns from this 
approach include the provision of new knowledge and the creation of product and 
business opportunities, delivering significant economic, societal and environmental 
progress and developing human capital to support future growth. 
The focus of future marine biotechnology research should aim to support the 
implementation of national and international policy, and enable the achievement of 
Ireland’s strategic objectives to develop a marine economy, via actions that:
• Respond to the prioritisation of health, food and materials in the national research 
agenda and other national strategies, and to the increased global interest in and 
demand for novel marine compounds; 
64  Our Ocean Wealth Development Task Force (2015) Report to the Inter-Departmental Marine Coordination Group. Available 
at: http://www.ouroceanwealth.ie/sites/default/files/sites/default/files/news/Final%20Our%20Ocean%20Wealth%20
Development%20Task%20Force%20Report.pdf
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• Maximise the potential to exploit Ireland’s diverse marine natural bioresources 
and to utilise waste from marine foods processing, which are a valuable reservoir of 
biological material; 
• Build on research excellence in marine bioresources by leveraging benefits from 
national investments in life sciences/biotechnology; 
• Expand the existing integrated research activities as a focal point for marine 
bioresources research, expand collaboration with industry, build on global research 
and commercial linkages, attract international expertise, train researchers and 
enable diverse industry sectors to create new products and processes; and 
• Further develop Ireland’s marine research capacity by increasing levels of 
participation in international research programmes. 
The definition of priority research areas/opportunities builds on recent successes and 
reflects Ireland’s scientific strengths, the potential of marine biotechnology research to 
contribute to the growth prospects of existing and emerging industry sectors, and new 
areas which bolster Ireland’s position as a competitive research performer. 
Targeting pharmaceuticals, food and health sectors, in addition to building on and 
enhancing key national industrial/economic development sectors, addresses the existing 
markets that can benefit from the outputs of marine biotechnology research. The same 
research competencies, which underpin existing market developments, are relevant to 
high-growth areas of cosmetics and cosmeceuticals, bioprocessing, nutrition, animal health 
and environmental products and processing technologies. Target areas for future research 
include: 
• Marine biomass – assess and exploit algae, fish, invertebrates and marine bacteria 
and generate biomass as a source of novel components;
• Food and health – functional foods utilising e.g. marine-derived lipids, 
carbohydrates, polyphenols, proteins, peptides and micronutrients;
• Biopharmaceuticals – new compounds and biological activities for human and 
animal health, cosmetics/cosmeceuticals and bioprocessing;
• Novel processes – bioprocessing to produce biochemical components; and
• Biomedical and environmental applications – health (medical devices) and 
environment; control and application of biofouling.
Estimates of the number of marine species, omitting bacteria and archaea, point to the 
possibility of the existence of between 700,000 to 1,000,000 species, of which about one 
quarter have to date been described65. Such abundance generates significant optimism 
65  Appeltans W et al (2012) The Magnitude of Global Marine Species Diversity. Current Biology 22, 2189–2202, December 4. 
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regarding future supply of novel materials from marine sources. Irish researchers use their 
extensive knowledge of marine species, acquired as a result of participating in NutraMara, 
Beaufort and other projects, to guide future research. Taking into account factors such as 
species knowledge, likely diversity, ease of access, available research infrastructure and 
relevant expertise, in addition to potential applications, future research targets include: 
• Marine algae – macro- and micro-algae, particularly Ireland’s extensive seaweed 
resources, that are known to be a novel source of bioactives;
• Fish and shellfish – including wild, farmed and processing waste streams, as a 
source of beneficial lipids, proteins, peptides and amino acids for health and food 
applications;
• Marine microorganisms/metagenomes – that are linked to human/marine life 
through biogeochemical cycles and ocean food webs, are recognised as having 
expanding dual roles in bioprocessing and as a source of bioactives; and 
• Marine invertebrates – deep sea and coastal sponges, cnidarians and ascidians, 
which are known sources of novel pharmaceutical/therapeutic and other useful 
compounds.
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Recommendations 
Harnessing the potential for Ireland to maximise marine biotechnology research in 
addressing economic and societal challenges and supporting the development of Ireland’s 
marine economy relies on the deployment of scientific expertise in focused areas. Marine 
biotechnology is an enabling technology in the creation of sustainable food production, 
food for health, therapeutics and novel materials. It is a technology that cuts across many 
different industry sectors, including those sectors where Ireland has developed international 
reputations such as food, medical devices and other health-related areas, including the 
production of therapeutics. The majority of Ireland’s marine biotechnology research takes 
place in the higher education sector and research institutes where it relies on expertise in 
marine and related areas in the biological, chemical and physical sciences. 
The strategy for marine biotechnology relies on identifying, harnessing and creating 
linkages between scientific excellence, national priorities and market opportunities. This 
strategy can be delivered by initiating actions that:
• Direct greater resources towards areas of science that underpin marine 
biotechnology and industry sectors that are positioned to secure access to market 
growth opportunities;
• Encourage and support partnerships between researchers and with industry;
• Stimulate the creation of, and maintain, partnerships between research providers in 
Ireland and with their international counterparts;
• Maximise the use of existing research infrastructure and ensure access to other 
essential infrastructure;
• Continue to attract new talent and expertise that is complementary to marine 
biotechnology; 
• Maintain a focus on priority areas of marine foods and functional ingredients, and 
marine origin bioactives for human and animal health applications, novel materials 
and bioprocessing;
• Support a balanced approach to research that includes targeting so-called “low-
hanging fruit”, whilst continuing the generation of knowledge to support longer-term 
opportunities; and
• Encourage leading researchers to collaborate under the auspices of a virtual 
research centre, thus becoming a focal point for marine biotechnology in Ireland.
Specifically, the Task Force recommends the following actions to achieve the ambitious 
targets set in national policies concerning the utilisation of Ireland’s marine bioresources: 
• Take steps to ensure Ireland continues to develop the critical infrastructure and 
research capability  required to maintain a leading position in international marine 
biotechnology research, specifically:
a) Build on the achievements and progress made in the NutraMara and 
Beaufort projects by providing funds to create a national virtual Marine 
Bioresources Research Centre with strong connections to other relevant 
supporting scientific capabilities and research centres (nationally and 
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internationally). This centre should have the capabilities for species/resource 
identification; the supply, identification and assessment of bio-actives and 
modes of action; and pilot-scale biorefining to eliminate bottle-necks in the 
discovery pipeline. 
b) Focus marine biotechnology research to support food; cosmetics and 
cosmeceuticals; biomaterials; bioprocessing; human/animal health and 
nutrition product and process development. 
c) Create, within the Marine Institute, and as an integral component of the 
virtual Marine Bioresources Research Centre, an Irish marine bioresources 
bio-bank/repository, initially built around the materials and data collected/
generated during the Beaufort and NutraMara projects. This can be enabled 
by further developing the current Marine Institute laboratory facilities 
to receive, process, preserve, and curate samples, and by implementing 
appropriate data management systems to ensure that data relating to 
species, samples, processing and the distribution of materials are developed 
and maintained to industry standards. A key function of the repository will 
be to make data and materials available to the research community and 
industry, and to enable Irish participation in international “biobanking” 
initiatives. 
• Ensure the continuation of the on-going, short to medium-term, and medium to 
long-term research priorities identified by the Task Force, aimed at the delivery of 
“low-hanging fruit” opportunities.
• Enhance the level of understanding of the distribution and availability of marine 
bioresources. In particular, provide knowledge about the distribution, available 
biomass and characteristics of commercially relevant species of Ireland’s seaweed 
stock.
• Strengthen the methods used to disseminate knowledge from publicly funded 
marine biotechnology and bioresources research, thereby increasing the level of 
understanding of the potential of these areas to contribute to economic progress, 
to provide industry with insights and access to the results of on-going research 
activities, and to stimulate greater industry-research interactions, linkages and 
collaboration. 
• Fully integrate Ireland’s marine bioresources sector into the wider bioeconomy via 
initiatives to expand the use of marine bioresources in food, biochemicals and other 
bio-based materials applications. 
• Overcome barriers related to the absence of scale and financial strength, that 
many SMEs in the marine bioresources sector face in attempting to develop marine 
biotechnology-enabled products, through the provision of dedicated interventions, 
support and technical assistance.
• Identify mechanisms to attract and facilitate the participation of expertise from 
areas identified as supportive of marine biotechnology/bioresources, e.g. ocean 
observation and mapping, genetics, bioinformatics, chemical synthesis, and process 
engineering.
• Develop and implement measures whereby all beneficiaries of public research funds 
that involve the collection of marine biological materials within Irish waters provide 
samples of all materials collected over the duration of the research grant to a 
national repository, at their own cost.
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ANNEX 
Marine Biotechnology Task Force Methodology
The Marine Biotechnology Task Force, with the support of the Marine Institute, designed 
a process to deliver on the Terms of Reference. This involved the Task Force requesting 
various information from the Marine Institute about international markets for marine 
biotechnology based products, Irish and European marine biotechnology related projects 
and resources involved in these projects. The Task Force invited and met researchers 
from an ad-hoc group which had presented proposals for a marine bioresources research 
centre to Science Foundation Ireland. 
The Task Force also considered the various national strategies and plans for science, 
technology, research and economic development. In supporting the work of the Task 
Force, the Marine Institute completed a number of information gathering exercises to fill 
knowledge gaps identified by the Task Force. Following the preparation of a draft report, 
the Task Force, with the support of the Marine Institute, held a workshop attended by 
researchers and companies. The final report took account of feedback from this workshop. 
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